Background: The mechanisms that regulate platelet biogenesis remain unclear; factors that trigger megakaryocytes (MKs) to initiate platelet production are poorly understood. Platelet formation begins with proplatelets, which are cellular extensions originating from the MK cell body. Objectives: Proplatelet formation is an asynchronous and dynamic process that poses unique challenges for researchers to accurately capture and analyze. We have designed an open-source, high-content, high-throughput, label-free analysis platform. Methods: Phase-contrast images of live, primary MKs are captured over a 24-hour period. Pixel-based machine-learning classification done by ilastik generates probability maps of key cellular features (circular MKs and branching proplatelets), which are processed by a customized CellProfiler pipeline to identify and filter structures of interest based on morphology. A subsequent reinforcement classification, by CellProfiler Analyst, improves the detection of cellular structures. Results: This workflow yields the percent of proplatelet production, area, count of proplatelets and MKs, and other statistics including skeletonization information for measuring proplatelet branching and length. We propose using a combination of these analyzed metrics, in particular the area measurements of MKs and proplatelets, when assessing in vitro proplatelet production. Accuracy was validated against manually counted images and an existing algorithm. We then used the new platform to test compounds known to cause thrombocytopenia, including bromodomain inhibitors, and uncovered previously unrecognized effects of drugs on proplatelet formation, thus demonstrating the utility of our analysis platform. Conclusion: This advance in creating unbiased data analysis will increase the scale and scope of proplatelet production studies and potentially serve as a valuable resource for investigating molecular mechanisms of thrombocytopenia.
Megakaryocytes (MKs) are specialized precursor cells committed to producing and proliferating platelets. In a cytoskeletal-driven process, mature MKs generate platelets by releasing thin cytoplasmic extensions, named proplatelets, into the sinusoids. Due to knowledge gaps in this process and mounting clinical demand for non-donor-based platelet sources, investigators are successfully developing artificial culture systems to recreate the environment of platelet biogenesis. Nevertheless, drawbacks in current methods entail elaborate procedures for stem cell enrichment, extensive growth periods, low MK yield, and poor proplatelet production. We propose a simple, robust method of primary MK culture that utilizes fetal livers from pregnant mice. Our technique reduces expansion time to 4 days, and generates ~15,000-20,000 MKs per liver. Approximately, 20-50% of these MKs produce structurally dense, high-quality proplatelets. In this review, we outline our method of MK culture and isolation.
Phosphoglycerate Dehydrogenase (PHGDH) gene, encoding the rate limiting enzyme of the serine synthesis pathway, is located at chromosome locus 1p12 and frequently amplified in melanoma. PHGDH is thought to be required for the proliferation of melanoma cells having chromosome 1p12 amplification. However, the role of PHGDH in chromosome 1p12 non-amplified melanoma is poorly understood. We observed that PHGDH is overexpressed in melanoma cell lines that do not harbor chromosome 1p12 amplification compared to melanocytes. Additionally, PHGDH is upregulated in melanomas compared to nevi. Hyperactivation of the MAPK pathway through activating mutations in BRAF or NRAS occurs in nearly all melanomas. Since PHGDH is universally upregulated in melanoma cells, we hypothesized that oncogenic BRAF mutations upregulate PHGDH expression, thereby generating a metabolic vulnerability in melanoma. Pharmacologic inactivation of the MAPK pathway using inhibitors of mutant BRAF/MEK/ERK resulted in the downregulation of PHGDH expression both in vitro and in xenograft tumors in vivo. On the other hand, acute expression of oncogenic BRAF (BRAFV600E) in melanocytes resulted in upregulation of PHGDH expression. Downregulation of PHGDH in 1p12 non-amplified melanoma cell lines decreased their cell proliferation and colony formation ability in vitro. We also observed that genetic knockdown of PHGDH in a BrafV600E/WT; Pten−/- (BPP) melanoma mouse model significantly increased survival. In addition to de-novo synthesis, serine can be taken up from extracellular compartments. Depletion of extracellular serine from the media resulted in upregulation of PHGDH expression and reduced proliferation of melanoma cells in vitro. By contrast, serine-glycine starvation in BPP mice did not affect tumor development or survival. These results implicate the dependency of melanoma tumors on de-novo serine synthesis through PHGDH. To investigate the therapeutic applicability of the PHGDH dependency, we inhibited the MAPK pathway with BRAF inhibitor along with extracellular serine-glycine depletion. We hypothesized that inhibiting the BRAF-mediated PHGDH expression along with extracellular serine-glycine starvation effectively depletes serine specifically in melanoma cells. Notably, cell viability was significantly reduced in vitro when BRAF inhibition was combined with serine-glycine depletion. Furthermore, our preliminary studies suggests that serine-glycine depletion potentiates the effect of mutant BRAF inhibition on melanoma growth in BPP mouse models. Overall, these results suggest the importance of PHGDH for melanoma cell proliferation and tumor growth irrespective of its amplification status. Combined MAPK inhibition and serine starvation may therefore exploit a metabolic vulnerability of melanoma cells and could be explored for melanoma therapy. Citation Format: Neel Jasani, Benjamin Posorske, Florian Karreth. BRAF- mediated PHGDH induction establishes a metabolic vulnerability in melanoma [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 1159.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.